Source: StreetInsider

Press Release: SynCardia : 20 Years after Landmark FDA Approval, SynCardia Remains World's Only Commercially Approved Total Artificial Heart

Few total artificial hearts make it to human clinical trials, and only the SynCardia Total Artificial Heart has met the rigorous requirements for commercial approval....

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more